Found: 21
Select item for more details and to access through your institution.
MatchMiner open‐source platform matches patients with cancer to precision medicine trials.
- Published in:
- 2023
- By:
- Publication type:
- Product Review
Poorer outcomes in young adult Black patients with acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 493, doi. 10.1002/cncr.34648
- By:
- Publication type:
- Article
First person profile: Cora N. Sternberg, MD: Between groundbreaking research in treating cancer through an understanding of its genetic makeup and sharing knowledge with other physicians, Dr Sternberg has had a rewarding career by giving patients with cancer hope of better outcomes
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 492, doi. 10.1002/cncr.34647
- By:
- Publication type:
- Article
A risk‐based postresection follow‐up strategy for hepatocellular carcinoma patients.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 569, doi. 10.1002/cncr.34601
- By:
- Publication type:
- Article
The mystery of posttreatment cancer surveillance.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 503, doi. 10.1002/cncr.34597
- By:
- Publication type:
- Article
Severe, life‐threatening, and fatal chronic health conditions after allogeneic blood or marrow transplantation in childhood.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 624, doi. 10.1002/cncr.34575
- By:
- Publication type:
- Article
Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 541, doi. 10.1002/cncr.34579
- By:
- Publication type:
- Article
Reply to "Plasma imatinib trough levels for predicting efficacy and toxicity in patients with chronic myeloid leukemia in chronic phase: Still a matter of debate!".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 645, doi. 10.1002/cncr.34578
- By:
- Publication type:
- Article
Plasma imatinib trough levels for predicting efficacy and toxicity in patients with chronic myeloid leukemia in chronic phase: Still a matter of debate!
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 643, doi. 10.1002/cncr.34577
- By:
- Publication type:
- Article
Baseline extracellular vesicle TGF‐β is a predictive biomarker for response to immune checkpoint inhibitors and survival in non–small cell lung cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 521, doi. 10.1002/cncr.34576
- By:
- Publication type:
- Article
Type I and Ir pleuropulmonary blastoma (PPB): A report from the International PPB/DICER1 Registry.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 600, doi. 10.1002/cncr.34593
- By:
- Publication type:
- Article
Differentially expressed messenger RNA/proteins can distinguish teratoma from necrosis in postchemotherapy retroperitoneal lymph node dissection tissue.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 634, doi. 10.1002/cncr.34571
- By:
- Publication type:
- Article
A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 580, doi. 10.1002/cncr.34570
- By:
- Publication type:
- Article
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: Where do we stand?
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 495, doi. 10.1002/cncr.34567
- By:
- Publication type:
- Article
Triple combination targeting methyltransferase, BCL‐2, and PD‐1 facilitates antileukemia responses in acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 531, doi. 10.1002/cncr.34566
- By:
- Publication type:
- Article
A retrospective study of cladribine and low‐dose cytarabine–based regimens for the treatment of chronic myelomonocytic leukemia and secondary acute myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 560, doi. 10.1002/cncr.34564
- By:
- Publication type:
- Article
Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 590, doi. 10.1002/cncr.34559
- By:
- Publication type:
- Article
Bendamustine in the treatment of patients with indolent non‐Hodgkin lymphoma refractory or relapse to rituximab treatment: An open‐label, single‐agent, multicenter study in China.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 551, doi. 10.1002/cncr.34544
- By:
- Publication type:
- Article
Reasons for refusal of the human papillomavirus vaccine among young cancer survivors.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 614, doi. 10.1002/cncr.34521
- By:
- Publication type:
- Article
Neurologic complications of breast cancer.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 505, doi. 10.1002/cncr.34518
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 4, p. 485, doi. 10.1002/cncr.33699
- Publication type:
- Article